Immunome

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunome and other ETFs, options, and stocks.

About IMNM

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas.

CEO

Clay B. Siegall

CEOClay B. Siegall

Employees

118

Employees118

Headquarters

Bothell, Washington

HeadquartersBothell, Washington

Founded

2006

Founded2006

Employees

118

Employees118

IMNM Key Statistics

Market cap

739.60M

Market cap739.60M

Price-Earnings ratio

-2.71

Price-Earnings ratio-2.71

Dividend yield

—

Dividend yield—

Average volume

1.43M

Average volume1.43M

High today

$8.87

High today$8.87

Low today

$8.45

Low today$8.45

Open price

$8.60

Open price$8.60

Volume

1.11M

Volume1.11M

52 Week high

$16.81

52 Week high$16.81

52 Week low

$5.15

52 Week low$5.15

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own IMNM. This list is generated using Robinhood data, and it’s not a recommendation.

Palantir Technologies

Riot Platforms

Immunome

Why Robinhood?

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. Show more

IMNM Key Statistics

Analyst ratings

100%

People also own

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas.